While some may ask whether the CT community should transition to low kV, Willi A. Kalender, Ph.D., a professor in the Institute of Medical Physics at the University of Erlangen, in Germany, asks why not.
While some may ask whether the CT community should transition to low kV, Willi A. Kalender, Ph.D., a professor in the Institute of Medical Physics at the University of Erlangen, in Germany, asks why not.
Kalender, a pioneer in CT widely acknowledged as the father of helical scanning, argued in a lecture at the ISCT symposium May 18 that transitioning from 120 kV to 80 kV will have no significant effect on image quality. He stated emphatically that reduced dose is not only possible for adult, but is essential for pediatric CT.
“With respect to physics and technology, the results should be the same, so the recommendation (across all makes of CT scanners) is to go to a lower kV,” he said. “Just possibly, if you do not have perfect results, however, talk to your manufacturer.”
Filtration techniques and components in the imaging chain can vary, according to Kalender.
“At different kV you have to make different efforts to keep the focal spot size the same, because these are very complicated electron guns these days,” he said. “But in principle you should get the same result. The differences are subtle.”
In an interview with Diagnostic Imaging, Kalender noted the importance of making adjustments in kV as part of an integrated approach to reducing radiation dose, one that involves making necessary adjustments to the mAs and utilizing algorithms that improve image quality, such as those involving iterative reconstruction, when available.
If a coherent approach is applied, the transition to lower tube energies need not stop at 80 kV. Kalender said he expects at least one vendor to make a 70-kV solution available commercially next year.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.